Search
-
-
-
NewWhy is the establishment of a High Commissioner for Deep Strategic Technologies crucial fo...
In a context where these innovations are advancing rapidly, Spain needs to modernize programs and instruments that enable harnessing our scientific and technological potential, transforming it into
-
-
New"The RNA is being investigated as a promising tool for the treatment of various diseases, ...
We spoke with Ana Isabel Jiménez, General Director of Sylentis, to learn how mRNA technology already provides alternative pathways that allow targeting key proteins involved in the development of
-
NewORYZON awarded with a grant for ORY-4001 from the ALS Association in the U.S.
To explore Oryzon’s clinical candidate ORY-4001 in ALS. The ALS Association to provide 500,000 USD funding.
-
